Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.

McHenry S, Tirath A, Tsai R, Sharma Y, Flores AG, Davidson NO, Fowler KJ, Ciorba MA, Deepak P.

Inflamm Bowel Dis. 2020 Jan 7. pii: izz324. doi: 10.1093/ibd/izz324. [Epub ahead of print]

PMID:
31907542
2.

Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients.

Zhang CRC, Nix D, Gregory M, Ciorba MA, Ostrander EL, Newberry RD, Spencer DH, Challen GA.

Exp Hematol. 2019 Dec;80:36-41.e3. doi: 10.1016/j.exphem.2019.11.008. Epub 2019 Dec 5.

PMID:
31812712
3.

Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.

Braga Neto MB, Gregory MH, Ramos GP, Bazerbachi F, Bruining DH, Abu Dayyeh BK, Kushnir VM, Raffals LE, Ciorba MA, Loftus EV, Deepak P.

Inflamm Bowel Dis. 2019 Oct 15. pii: izz236. doi: 10.1093/ibd/izz236. [Epub ahead of print]

PMID:
31613968
4.

The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.

Gregory MH, Ciorba MA, Wiitala WL, Stidham RW, Higgins P, Morley SC, Hou JK, Feagins LA, Govani SM, Cohen-Mekelburg SA, Waljee AK.

Inflamm Bowel Dis. 2019 Aug 27. pii: izz189. doi: 10.1093/ibd/izz189. [Epub ahead of print]

PMID:
31504531
5.

Hyaluronic Acid Binding to TLR4 Promotes Proliferation and Blocks Apoptosis in Colon Cancer.

Makkar S, Riehl TE, Chen B, Yan Y, Alvarado DM, Ciorba MA, Stenson WF.

Mol Cancer Ther. 2019 Dec;18(12):2446-2456. doi: 10.1158/1535-7163.MCT-18-1225. Epub 2019 Sep 4.

PMID:
31484704
6.

Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.

Alvarado DM, Chen B, Iticovici M, Thaker AI, Dai N, VanDussen KL, Shaikh N, Lim CK, Guillemin GJ, Tarr PI, Ciorba MA.

Gastroenterology. 2019 Oct;157(4):1093-1108.e11. doi: 10.1053/j.gastro.2019.07.013. Epub 2019 Jul 17.

PMID:
31325428
7.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2019 Jul 1;129(7):2980. doi: 10.1172/JCI130874. Epub 2019 Jul 1. No abstract available.

8.

Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.

Rengarajan S, Vivio EE, Parkes M, Peterson DA, Roberson EDO, Newberry RD, Ciorba MA, Hsieh CS.

Gut Microbes. 2019 Jun 16:1-16. doi: 10.1080/19490976.2019.1626683. [Epub ahead of print]

PMID:
31203722
9.

Crohn's Disease Is Associated With an Increased Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study Using Magnetic Resonance Proton Density Fat Fraction Mapping.

McHenry S, Sharma Y, Tirath A, Tsai R, Mintz A, Fraum TJ, Salter A, Browning JD, Flores AG, Davidson NO, Fowler KJ, Ciorba MA, Deepak P.

Clin Gastroenterol Hepatol. 2019 Dec;17(13):2816-2818. doi: 10.1016/j.cgh.2019.02.045. Epub 2019 Mar 12.

PMID:
30876963
10.

Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.

Li E, Zhang Y, Tian X, Wang X, Gathungu G, Wolber A, Shiekh SS, Sartor RB, Davidson NO, Ciorba MA, Zhu W, Nelson LM, Robertson CE, Frank DN.

PLoS One. 2019 Feb 28;14(2):e0213108. doi: 10.1371/journal.pone.0213108. eCollection 2019.

11.

Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.

Gregory M, Weaver KN, Hoversten P, Hicks SB, Patel D, Ciorba MA, Gutierrez AM, Beniwal-Patel P, Palam S, Syal G, Herfarth HH, Christophi G, Raffals L, Barnes EL, Deepak P.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1569-1576. doi: 10.1093/ibd/izz030.

PMID:
30810748
12.

Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and Infliximab.

Gregory MH, Ciorba MA, Deepak P, Christophi GP.

Inflamm Bowel Dis. 2019 Jun 18;25(7):e87-e88. doi: 10.1093/ibd/izz015. No abstract available.

PMID:
30753456
13.

IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.

Bishnupuri KS, Alvarado DM, Khouri AN, Shabsovich M, Chen B, Dieckgraefe BK, Ciorba MA.

Cancer Res. 2019 Mar 15;79(6):1138-1150. doi: 10.1158/0008-5472.CAN-18-0668. Epub 2019 Jan 24.

PMID:
30679179
14.

Insights into How Probiotics Colonize the Healthy Human Gut.

Ferreiro A, Dantas G, Ciorba MA.

Gastroenterology. 2019 Feb;156(3):820-822. doi: 10.1053/j.gastro.2019.01.022. Epub 2019 Jan 16. No abstract available.

PMID:
30659834
15.

Anti-Tumour Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections after Arthroplasty.

Gregory MH, McKinnon A, Stwalley D, Hippensteel KJ, Loftus EV Jr, Ciorba MA, Olsen MA, Deepak P.

J Crohns Colitis. 2019 Feb 1;13(2):182-188. doi: 10.1093/ecco-jcc/jjy148.

PMID:
30256926
16.

Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells.

Riehl TE, Alvarado D, Ee X, Zuckerman A, Foster L, Kapoor V, Thotala D, Ciorba MA, Stenson WF.

Gut. 2019 Jun;68(6):1003-1013. doi: 10.1136/gutjnl-2018-316226. Epub 2018 Jun 22.

PMID:
29934438
17.

Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.

Sofia MA, Ciorba MA, Meckel K, Lim CK, Guillemin GJ, Weber CR, Bissonnette M, Pekow JR.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1471-1480. doi: 10.1093/ibd/izy103.

18.

Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease.

VanDussen KL, Stojmirović A, Li K, Liu TC, Kimes PK, Muegge BD, Simpson KF, Ciorba MA, Perrigoue JG, Friedman JR, Towne JE, Head RD, Stappenbeck TS.

Gastroenterology. 2018 Sep;155(3):815-828. doi: 10.1053/j.gastro.2018.05.028. Epub 2018 May 18.

19.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2018 Aug 1;128(8):3298-3311. doi: 10.1172/JCI97659. Epub 2018 Jun 25. Erratum in: J Clin Invest. 2019 Jul 1;129(7):2980.

20.

Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis.

Wardill HR, Van Sebille YZA, Ciorba MA, Bowen JM.

Curr Opin Support Palliat Care. 2018 Jun;12(2):187-197. doi: 10.1097/SPC.0000000000000338.

PMID:
29547491
21.

A Role for Salivary Peptides in the Innate Defense Against Enterotoxigenic Escherichia coli.

Brown JW, Badahdah A, Iticovici M, Vickers TJ, Alvarado DM, Helmerhorst EJ, Oppenheim FG, Mills JC, Ciorba MA, Fleckenstein JM, Bullitt E.

J Infect Dis. 2018 Apr 11;217(9):1435-1441. doi: 10.1093/infdis/jiy032.

22.

Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.

Afzali A, Ciorba MA, Schwartz DA, Sharaf M, Fourment C, Ritter T, Wolf DC, Shafran I, Randall CW, Kane SV.

Inflamm Bowel Dis. 2017 Dec 19;24(1):2-4. doi: 10.1093/ibd/izx015.

PMID:
29272481
23.

De-novo Inflammatory Bowel Disease After Bariatric Surgery: A Large Case Series.

Braga Neto MB, Gregory M, Ramos GP, Loftus EV Jr, Ciorba MA, Bruining DH, Bazerbachi F, Abu Dayyeh BK, Kushnir VM, Shah M, Collazo-Clavell ML, Raffals LE, Deepak P.

J Crohns Colitis. 2018 Mar 28;12(4):452-457. doi: 10.1093/ecco-jcc/jjx177.

PMID:
29272375
24.

Progress in PD-1-based Immunotherapy: New Mechanistic Insight May Provide Expanded Hope for Application to Colon and Gastrointestinal Cancers.

Park H, Chen B, Ciorba MA.

Gastroenterology. 2017 Oct;153(4):1162-1163. doi: 10.1053/j.gastro.2017.08.050. Epub 2017 Sep 1. No abstract available.

PMID:
28867277
25.

Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions.

Sheikh A, Rashu R, Begum YA, Kuhlman FM, Ciorba MA, Hultgren SJ, Qadri F, Fleckenstein JM.

PLoS Negl Trop Dis. 2017 May 22;11(5):e0005586. doi: 10.1371/journal.pntd.0005586. eCollection 2017 May.

26.

Pneumococcal Disease in Inflammatory Bowel Disease: Justification to Vaccinate at Diagnosis.

Cushing KC, Kanuri N, Ciorba MA.

Gastroenterology. 2016 Aug;151(2):365-6. doi: 10.1053/j.gastro.2016.06.027. Epub 2016 Jun 30. No abstract available.

27.

Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach.

Christophi GP, Rengarajan A, Ciorba MA.

Clin Exp Gastroenterol. 2016 May 19;9:125-30. doi: 10.2147/CEG.S80237. eCollection 2016. Review.

28.

Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.

Patel A, Hasak S, Cassell B, Ciorba MA, Vivio EE, Kumar M, Gyawali CP, Sayuk GS.

Aliment Pharmacol Ther. 2016 Aug;44(3):246-58. doi: 10.1111/apt.13677. Epub 2016 May 30.

29.

Probiotic Gut Bacteria Enhance Cancer Immunotherapy in a Mouse Model of Melanoma.

Dey N, Ciorba MA.

Gastroenterology. 2016 Jul;151(1):206-7. doi: 10.1053/j.gastro.2016.05.015. Epub 2016 May 26. No abstract available.

PMID:
27238844
30.

Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera.

Kuhlmann FM, Santhanam S, Kumar P, Luo Q, Ciorba MA, Fleckenstein JM.

Am J Trop Med Hyg. 2016 Aug 3;95(2):440-3. doi: 10.4269/ajtmh.16-0161. Epub 2016 May 9.

31.

Advances in understanding and improving gastrointestinal symptoms during supportive and palliative care: a decade of progress.

Ciorba MA.

Curr Opin Support Palliat Care. 2016 Jun;10(2):149-51. doi: 10.1097/SPC.0000000000000215. No abstract available.

32.

Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice.

Vivio EE, Kanuri N, Gilbertsen JJ, Monroe K, Dey N, Chen CH, Gutierrez AM, Ciorba MA.

J Crohns Colitis. 2016 Apr;10(4):402-9. doi: 10.1093/ecco-jcc/jjv226. Epub 2015 Dec 17.

33.

Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation.

Cushing K, Alvarado DM, Ciorba MA.

Clin Transl Gastroenterol. 2015 Aug 27;6:e108. doi: 10.1038/ctg.2015.34. No abstract available.

34.

Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.

Santhanam S, Alvarado DM, Ciorba MA.

Transl Res. 2016 Jan;167(1):67-79. doi: 10.1016/j.trsl.2015.07.003. Epub 2015 Aug 3. Review.

35.

Correction: IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype.

Lee A, Kanuri N, Zhang Y, Sayuk GS, Li E, Ciorba MA.

PLoS One. 2015 Jul 14;10(7):e0133098. doi: 10.1371/journal.pone.0133098. eCollection 2015. No abstract available.

36.

Scap and the intestinal epithelial stem cell niche: new insights from lipid biology.

Ciorba MA.

J Lipid Res. 2015 Aug;56(8):1381-2. doi: 10.1194/jlr.C061309. Epub 2015 Jun 10. No abstract available.

37.

Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?

Christophi GP, Ciorba MA.

J Clin Gastroenterol. 2015 Aug;49(7):539-40. doi: 10.1097/MCG.0000000000000352. No abstract available.

38.

Probiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to action.

Ciorba MA, Hallemeier CL, Stenson WF, Parikh PJ.

Curr Opin Support Palliat Care. 2015 Jun;9(2):157-62. doi: 10.1097/SPC.0000000000000134. Review.

39.

IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.

Lee A, Kanuri N, Zhang Y, Sayuk GS, Li E, Ciorba MA.

PLoS One. 2014 Dec 26;9(12):e115848. doi: 10.1371/journal.pone.0115848. eCollection 2014. Erratum in: PLoS One. 2015;10(7):e0133098.

40.

Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays.

VanDussen KL, Marinshaw JM, Shaikh N, Miyoshi H, Moon C, Tarr PI, Ciorba MA, Stappenbeck TS.

Gut. 2015 Jun;64(6):911-20. doi: 10.1136/gutjnl-2013-306651. Epub 2014 Jul 9.

41.

Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.

Iskandar HN, Cassell B, Kanuri N, Gyawali CP, Gutierrez A, Dassopoulos T, Ciorba MA, Sayuk GS.

J Clin Gastroenterol. 2014 May-Jun;48(5):423-9. doi: 10.1097/MCG.0000000000000049.

42.

Kynurenine pathway metabolites: relevant to vitamin B-6 deficiency and beyond.

Ciorba MA.

Am J Clin Nutr. 2013 Oct;98(4):863-4. doi: 10.3945/ajcn.113.072025. Epub 2013 Aug 28. No abstract available.

43.

IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.

Thaker AI, Rao MS, Bishnupuri KS, Kerr TA, Foster L, Marinshaw JM, Newberry RD, Stenson WF, Ciorba MA.

Gastroenterology. 2013 Aug;145(2):416-25.e1-4. doi: 10.1053/j.gastro.2013.05.002. Epub 2013 May 10.

44.

Indoleamine 2,3 dioxygenase in intestinal disease.

Ciorba MA.

Curr Opin Gastroenterol. 2013 Mar;29(2):146-52. doi: 10.1097/MOG.0b013e32835c9cb3. Review.

45.

Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS).

Thaker AI, Shaker A, Rao MS, Ciorba MA.

J Vis Exp. 2012 Sep 11;(67). pii: 4100. doi: 10.3791/4100.

46.

A gastroenterologist's guide to probiotics.

Ciorba MA.

Clin Gastroenterol Hepatol. 2012 Sep;10(9):960-8. doi: 10.1016/j.cgh.2012.03.024. Epub 2012 Apr 10. Review.

47.

Biomarkers in inflammatory bowel disease: current practices and recent advances.

Iskandar HN, Ciorba MA.

Transl Res. 2012 Apr;159(4):313-25. doi: 10.1016/j.trsl.2012.01.001. Epub 2012 Feb 1. Review.

48.

Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.

Ciorba MA, Riehl TE, Rao MS, Moon C, Ee X, Nava GM, Walker MR, Marinshaw JM, Stappenbeck TS, Stenson WF.

Gut. 2012 Jun;61(6):829-38. doi: 10.1136/gutjnl-2011-300367. Epub 2011 Oct 24.

49.

Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity.

Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, Ciorba MA.

Inflamm Bowel Dis. 2012 Jul;18(7):1214-20. doi: 10.1002/ibd.21849. Epub 2011 Aug 5.

50.

Magnetic resonance enterography: safe and effective imaging for stricturing Crohn's disease.

Ha CY, Kumar N, Raptis CA, Narra VR, Ciorba MA.

Dig Dis Sci. 2011 Oct;56(10):2906-13. doi: 10.1007/s10620-011-1781-0. Epub 2011 Jun 19.

Supplemental Content

Loading ...
Support Center